AQR Arbitrage’s Achillion Pharmaceuticals ACHN Stock Holding History

AQR Arbitrage’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,161,883	Closed	-$19.1M	–	637
2019 Q4	$19.1M	Buy	+3,161,883	New	+$18.3M	0.32%	69

AQR Arbitrage's ACHN Position: Q1 2020 in Review

AQR Arbitrage sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 3,161,883 shares — an estimated $19.1M sold.

AQR Arbitrage first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $19.1M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

AQR Arbitrage reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
AQR Arbitrage sold 3,161,883 Achillion Pharmaceuticals shares in Q1 2020, an estimated $19.1M.
AQR Arbitrage first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
AQR Arbitrage's Achillion Pharmaceuticals position peaked at $19.1M in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on AQR Arbitrage's 13F filing for Q1 2020, filed 15 May 2020.